1-(tetrahydrofuran-2-yl)-N-(thiazol-2-ylmethyl)methanamine dihydrochloride

Catalog No. :
ACGJZT455
CAS No. :
1332530-56-9
Molecular Formula :
C9H16Cl2N2OS
Molecular Weight :
271.21

IUPAC Name:1-(tetrahydrofuran-2-yl)-N-(thiazol-2-ylmethyl)methanamine dihydrochloride

1-(tetrahydrofuran-2-yl)-N-(thiazol-2-ylmethyl)methanamine dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$207.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(tetrahydrofuran-2-yl)-N-(thiazol-2-ylmethyl)methanamine dihydrochloride
IUPAC Name1-(tetrahydrofuran-2-yl)-N-(thiazol-2-ylmethyl)methanamine dihydrochloride
Molecular FormulaC9H16Cl2N2OS
Molecular Weight271.21
SMILESC1=CSC(CNCC2CCCO2)=N1.Cl.Cl
InChI KeyWZKUYCJXJXMCCP-UHFFFAOYSA-N
Synonym1-(oxolan-2-yl)-N-(1,3-thiazol-2-ylmethyl)methanamine:dihydrochloride;(oxolan-2-yl)methyl][(1,3-thiazol-2-yl)methyl]amine dihydrochloride
CAS No.1332530-56-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACGJZT455 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGWHA519 route compound structure diagram
    ACGWHA51910200-59-6 In Stock
  4. Then
  5. ACGJZT455 route product structure diagram
    ACGJZT4551332530-56-9
Inquiry

2. ACGJZT455 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKBUR384 route compound structure diagram
    ACKBUR384850852-85-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGJZT455 route product structure diagram
    ACGJZT4551332530-56-9
Inquiry

Comments (0)